NM_033123.4:c.1759_1760delCT
Variant names:
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PVS1_ModeratePM2
The NM_033123.4(PLCZ1):c.1759_1760delCT(p.Leu587ValfsTer6) variant causes a frameshift change. The variant allele was found at a frequency of 0.00000205 in 1,460,418 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000021 ( 0 hom. )
Consequence
PLCZ1
NM_033123.4 frameshift
NM_033123.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.93
Publications
0 publications found
Genes affected
PLCZ1 (HGNC:19218): (phospholipase C zeta 1) The protein encoded by this gene is a member of the phosphoinositide-specific phospholipase C family. Members in this family, classified into six isotypes that are tissue- and organ-specific, hydrolyze phosphatidylinositol 4,5-bisphosphate just before the phosphate group to yield diacylglycerol and inositol 1,4,5-trisphosphate. This protein localizes to the acrosome in spermatozoa and elicits Ca(2+) oscillations and egg activation during fertilization that leads to early embryonic development. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2012]
PIK3C2G (HGNC:8973): (phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma) The protein encoded by this gene belongs to the phosphoinositide 3-kinase (PI3K) family. PI3-kinases play roles in signaling pathways involved in cell proliferation, oncogenic transformation, cell survival, cell migration, and intracellular protein trafficking. This protein contains a lipid kinase catalytic domain as well as a C-terminal C2 domain, a characteristic of class II PI3-kinases. C2 domains act as calcium-dependent phospholipid binding motifs that mediate translocation of proteins to membranes, and may also mediate protein-protein interactions. This gene may play a role in several diseases, including type II diabetes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.0372 CDS is truncated, and there are 0 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLCZ1 | NM_033123.4 | c.1759_1760delCT | p.Leu587ValfsTer6 | frameshift_variant | Exon 15 of 15 | ENST00000266505.12 | NP_149114.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLCZ1 | ENST00000266505.12 | c.1759_1760delCT | p.Leu587ValfsTer6 | frameshift_variant | Exon 15 of 15 | 1 | NM_033123.4 | ENSP00000266505.7 | ||
PLCZ1 | ENST00000648272.1 | c.1882_1883delCT | p.Leu628ValfsTer6 | frameshift_variant | Exon 14 of 14 | ENSP00000497636.1 | ||||
PLCZ1 | ENST00000539875.5 | c.1180_1181delCT | p.Leu394ValfsTer6 | frameshift_variant | Exon 11 of 11 | 1 | ENSP00000445026.1 | |||
PLCZ1 | ENST00000318197.10 | n.*1624_*1625delCT | non_coding_transcript_exon_variant | Exon 15 of 15 | 1 | ENSP00000326397.6 | ||||
PLCZ1 | ENST00000318197.10 | n.*1624_*1625delCT | 3_prime_UTR_variant | Exon 15 of 15 | 1 | ENSP00000326397.6 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1460418Hom.: 0 AF XY: 0.00000275 AC XY: 2AN XY: 726558 show subpopulations
GnomAD4 exome
AF:
AC:
3
AN:
1460418
Hom.:
AF XY:
AC XY:
2
AN XY:
726558
show subpopulations
African (AFR)
AF:
AC:
0
AN:
33394
American (AMR)
AF:
AC:
0
AN:
44600
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26066
East Asian (EAS)
AF:
AC:
0
AN:
39664
South Asian (SAS)
AF:
AC:
0
AN:
86236
European-Finnish (FIN)
AF:
AC:
0
AN:
53388
Middle Eastern (MID)
AF:
AC:
0
AN:
5752
European-Non Finnish (NFE)
AF:
AC:
3
AN:
1111014
Other (OTH)
AF:
AC:
0
AN:
60304
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.558
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Jan 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
PLCZ1: PM2 -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.